Application Context: Preclinical Exploration Focused on Cytoprotection
Research on Humanin is primarily centered on supporting cell survival under stress conditions, rather than directly enhancing athletic performance.
Neuroprotection: In cellular and animal models of Alzheimer's disease (AD), Humanin inhibits amyloid-beta (Aβ)-induced neuronal apoptosis and reduces both oxidative stress and tau hyperphosphorylation. Notably, because natural Humanin has a short half-life in vivo, research frequently employs its analog, HNG (S14G-Humanin), which is approximately 1,000 times more potent in cellular assays than the native sequence.
Cardioprotection: In rat models of myocardial infarction, pretreatment with Humanin lowers levels of myocardial injury markers (such as AST, LDH, CK-MB, and troponin I) and mitigates tissue necrosis and congestion.
Metabolic Regulation: Humanin improves insulin sensitivity, reduces visceral fat, and induces autophagy in skeletal muscle. One study demonstrated that Humanin increases autophagic flux in the skeletal muscle of aged mice; furthermore, autophagy is essential for the lifespan-extending effects of Humanin observed in *C. elegans*.
Exercise Response: Plasma Humanin levels in humans undergo transient changes following acute, high-intensity exercise, suggesting that it may function as a "mitochondria-derived myokine" involved in exercise-related stress signaling. However, data in this area remain limited, and the trends following long-term training adaptations are not yet fully understood.
Physical Mechanism: A Cytoprotective Network Involving Multiple Intersecting Pathways
Humanin does not operate through a simple receptor-ligand model; instead, it functions via parallel intracellular and extracellular pathways.
Intracellular Anti-apoptosis: Humanin can directly bind to pro-apoptotic BCL-2 family proteins (such as BAX and BID), sequestering them within amyloid-like fibrillar structures. This process blocks mitochondrial outer membrane permeabilization (MOMP) and the subsequent caspase cascade. This "conformational conversion" mechanism serves as the core molecular basis for its cytoprotective effects. Extracellular Receptor Pathways: Humanin can act as a ligand, binding to formyl peptide receptor-like receptors (FPRL1/FPRL2) to activate downstream survival signaling. Additionally, it can bind to IGFBP-3, interfering with the cell-death signaling mediated by the latter.
Autophagy Induction: Humanin can upregulate autophagy pathways, assisting cells in clearing damaged mitochondria and protein aggregates, thereby maintaining homeostasis under metabolic stress.
Structural Basis: Humanin features a positively charged N-terminus, a hydrophobic central region, and a negatively charged C-terminus. The Pro3–Pro19 segment serves as the "neuroprotective core domain," and replacing Ser14 with Gly (creating the variant HNG) significantly enhances its protective efficacy.
Theoretical Benefits in Bodybuilding
Important Disclaimer: The following potential benefits have not been validated through human clinical trials involving bodybuilders or athletes; they are based solely on mechanistic deductions and data from animal or cellular studies.
1. Cytoprotection Following High-Intensity Training
Bodybuilding training-particularly the mechanical tension and metabolic stress induced during the eccentric phase-can trigger apoptotic signaling in muscle cells. Theoretically, Humanin's anti-apoptotic mechanisms could reduce stress-induced muscle cell loss, supporting cell survival during the recovery window. Evidence Level: Low (mechanistic deduction + animal data).
2. Metabolic Adaptation and Insulin Sensitivity
In animal models, Humanin has been shown to improve insulin sensitivity and reduce visceral fat. This characteristic is theoretically appealing for managing metabolic stress during bodybuilding contest preparation. However, it remains entirely unknown whether exogenous supplementation would produce similar effects in humans. Evidence Level: Low (rodent data).
3. Involvement in Exercise-Induced Stress Signaling
The transient fluctuations of Humanin in skeletal muscle and plasma following acute exercise suggest it may be a component of the adaptive response to physical activity. Nevertheless, there is no evidence to indicate whether exogenous supplementation mimics or enhances this endogenous response. Evidence Level: Very Low (observational data). 4. A Cautious Assessment of Its "Suitability for Bodybuilding"
The primary research context for Humanin involves neurodegenerative diseases and cardiac ischemia, rather than muscle hypertrophy or strength output. Incorporating it into a bodybuilding supplement regimen is, in essence, an extrapolation of the concept of "cytoprotection" rather than an evidence-based application. Compared to MOTS-c-which focuses on metabolism and exercise capacity-Humanin has even less direct relevance to the context of bodybuilding.
Dietary and Pharmacological Considerations
Dietary Aspects: There are no known food interactions. However, it should be noted that Humanin's metabolic effects are linked to insulin sensitivity. If combined with large amounts of refined carbohydrates or insulin secretagogues, there is theoretical uncertainty regarding blood glucose regulation-though no human data exist to provide specific guidance.
Risks of Drug Interactions (Based on Mechanistic Deduction):
Chemotherapeutic Agents: Humanin's anti-apoptotic properties pose a potential risk here. A study on glioblastoma indicated that chemotherapy upregulates Humanin expression, while the Humanin analog HNGF6A was found to enhance both chemoresistance and the migratory capacity of glioma cells. Another study involving mice with triple-negative breast cancer also suggests that Humanin may promote tumor progression and impair the efficacy of doxorubicin. Individuals with a history of cancer or those currently undergoing chemotherapy should strictly avoid its use.
Antidiabetic Drugs/Insulin: Since Humanin improves insulin sensitivity, combining it with antidiabetic medications could theoretically increase the risk of hypoglycemia (though no clinical reports exist).
General Safety Note: Neither Humanin nor HNG has been approved by the FDA, and there are no completed human intervention trials to establish appropriate dosages, efficacy, or long-term safety. Products sold on the market as "Humanin" are often actually HNG analogs; the potency of the two cannot be considered equivalent.
Why Choose Us
In the field of Humanin-an area still in the research phase and lacking human data-the quality of raw materials and the reliability of the supply chain are the primary factors that determine the credibility of research outcomes. We position ourselves as a primary-source provider for rigorous researchers, offering products with full traceability:
Direct-from-Manufacturer: We are the manufacturer, not a middleman or trader. Our end-to-end control-from peptide synthesis to purification and packaging-eliminates the risks of batch-to-batch variation and cross-contamination often introduced by intermediaries.
Professional Production Capabilities: Utilizing a Solid-Phase Peptide Synthesis (SPPS) platform combined with HPLC purification, we effectively minimize by-products such as truncated or incomplete sequences-a critical advantage for short peptides like Humanin (24 amino acids).
Reliable Supply: With robust reserves of core raw materials and strategic production planning, we ensure a consistent supply, helping you avoid experimental interruptions or project delays caused by stock shortages.
High Purity and Consistent Quality: Every batch undergoes rigorous verification via HPLC and mass spectrometry. We provide a Certificate of Analysis (COA) for each lot, ensuring that purity specifications are both verifiable and traceable. Such batch-to-batch consistency is the foundation for reproducibility in animal and cell-based studies.
Dedicated After-Sales Support: Our technical team is available to assist with product specifications (e.g., distinguishing between native Humanin and HNG analogs), as well as guidance on dissolution and storage, helping to prevent loss of bioactivity due to improper handling.
A Final Note: Choosing a reliable supplier ensures you receive exactly what you ordered. However, given the current lack of clinical evidence for Humanin in humans, questions regarding whether to use it, how to use it, and what the associated risks might be should be evaluated with the caution and judgment expected of a professional researcher. We provide a reliable research tool, not clinical advice.
FAQ:
Q: Where are your products manufactured?
A: Our products are manufactured in Shenzhen, China.
Q: What is the minimum order quantity (MOQ)?
A: The minimum order quantity is 10 vials/units.
Q: How quickly do you ship after an order is placed?
A: For items in stock, we arrange shipment within 24 hours.
Q: What purity levels do you offer?
A: Our standard purity is 99%.
Q: Which shipping carriers do you use?
A: We offer shipping via FedEx, DHL, UPS, and postal services.
Q: How long does shipping take?
A: Approximately 10–15 days. Q: Can you provide a Certificate of Analysis (COA) and an HPLC (High-Performance Liquid Chromatography) test report?
A: Yes, these can be provided. All shipments undergo professional testing prior to dispatch.
Q: Do you offer OEM (private label) services?
A: Yes, OEM services are available, subject to a minimum order quantity (MOQ).
Q: How do you handle after-sales issues?
A: If a quality issue attributable to our production is confirmed after the customer has received the goods, we offer free replacement or a refund. We operate with a pragmatic and responsible approach-we address all concerns proactively and appropriately, without evasion or deflection, and are fully committed to safeguarding our customers' interests.
Q: What payment methods do you accept?
A: We accept bank transfers, Bitcoin, TransferWise, and Xoom.
Hot Tags: humanin (10 mg/vial) – high-purity peptide for research use; supplier based in china., China humanin (10 mg/vial) – high-purity peptide for research use; supplier based in china. manufacturers, suppliers, factory
